XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -62.44%183.4M | -62.44%183.4M | -59.27%148.1M | -70.48%169.7M | -43.12%340.1M | -24.35%488.3M | -24.35%488.3M | -41.94%363.6M | -20.50%574.8M | -34.73%597.9M |
-Cash and cash equivalents | -62.44%183.4M | -62.44%183.4M | -59.27%148.1M | -70.48%169.7M | -43.12%340.1M | -24.35%488.3M | -24.35%488.3M | -41.94%363.6M | -20.50%574.8M | -26.74%597.9M |
Receivables | -9.87%560.4M | -9.87%560.4M | 8.64%712.9M | 15.26%694.3M | 34.87%636.2M | 4.45%621.8M | 4.45%621.8M | 55.76%656.2M | 49.63%602.4M | 13.99%471.7M |
-Accounts receivable | 13.90%560.4M | 13.90%560.4M | 10.92%538.4M | 12.51%507.2M | 0.78%475.4M | 4.08%492M | 4.08%492M | 15.21%485.4M | 11.97%450.8M | 13.99%471.7M |
-Taxes receivable | ---- | ---- | -18.83%66.8M | 15.02%87.3M | --70M | -25.73%45.9M | -25.73%45.9M | --82.3M | --75.9M | ---- |
-Other receivables | ---- | ---- | 21.69%107.7M | 31.84%99.8M | --90.8M | 37.99%83.9M | 37.99%83.9M | --88.5M | --75.7M | ---- |
Inventory | 10.42%1.07B | 10.42%1.07B | 33.23%1.22B | 28.57%1.18B | 23.49%1.06B | 21.02%968.3M | 21.02%968.3M | 22.21%916M | 20.50%914.6M | 16.07%858.8M |
Prepaid assets | ---- | ---- | 22.20%69.9M | 102.47%73.7M | --62.3M | 28.18%55.5M | 28.18%55.5M | --57.2M | --36.4M | ---- |
Other current assets | 1,240.44%245.3M | 1,240.44%245.3M | -14.56%31.1M | -51.54%26.7M | -91.84%16.7M | 42.97%18.3M | 42.97%18.3M | -84.81%36.4M | -72.84%55.1M | 13.04%204.6M |
Total current assets | -4.89%2.06B | -4.89%2.06B | 7.98%2.19B | -1.39%2.15B | 0.35%2.14B | 2.41%2.16B | 2.41%2.16B | -0.35%2.03B | 4.59%2.18B | -5.23%2.13B |
Non current assets | ||||||||||
Net PPE | -3.20%669.3M | -3.20%669.3M | 59.66%841.4M | 51.67%792.8M | 35.29%691.2M | 28.47%691.4M | 28.47%691.4M | 25.03%527M | 32.33%522.7M | 26.52%510.9M |
-Gross PPE | ---- | ---- | --841.4M | --792.8M | --691.2M | 23.42%1.22B | 23.42%1.22B | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -17.35%-524.2M | -17.35%-524.2M | ---- | ---- | ---- |
Goodwill and other intangible assets | 237.62%3.08B | 237.62%3.08B | 193.21%2.5B | 187.56%2.47B | 45.45%1.2B | 25.34%913.1M | 25.34%913.1M | 43.24%853M | 36.30%858.3M | 34.98%825.8M |
-Goodwill | ---- | ---- | 162.81%1.47B | 158.79%1.44B | 42.59%751.9M | 27.32%582.6M | 27.32%582.6M | 47.08%561.1M | 40.81%557.9M | 37.21%527.3M |
-Other intangible assets | ---- | ---- | 251.66%1.03B | 240.98%1.02B | 50.49%449.2M | 22.00%330.5M | 22.00%330.5M | 36.40%291.9M | 28.65%300.4M | 31.21%298.5M |
Non current deferred assets | ---- | ---- | --340.9M | --303.2M | --280.1M | 286.98%297.2M | 286.98%297.2M | ---- | ---- | ---- |
Other non current assets | ---- | ---- | -41.96%238.1M | -36.62%185.5M | -34.19%193.6M | 18.63%184M | 18.63%184M | 44.79%410.2M | 7.37%292.7M | 3.48%294.2M |
Total non current assets | 79.90%3.75B | 79.90%3.75B | 119.05%3.92B | 124.03%3.75B | 45.07%2.37B | 39.18%2.09B | 39.18%2.09B | 37.68%1.79B | 29.01%1.67B | 25.46%1.63B |
Total assets | 36.72%5.81B | 36.72%5.81B | 60.04%6.11B | 53.04%5.9B | 19.73%4.51B | 17.67%4.25B | 17.67%4.25B | 14.47%3.82B | 13.95%3.86B | 6.00%3.76B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -34.99%234.1M | -34.99%234.1M | 25.34%227.5M | 16.68%220.3M | 1.48%199.1M | 27.51%360.1M | 27.51%360.1M | 15.09%181.5M | 21.89%188.8M | 21.71%196.2M |
-accounts payable | 15.49%234.1M | 15.49%234.1M | 25.34%227.5M | 16.68%220.3M | 1.48%199.1M | 13.62%202.7M | 13.62%202.7M | 15.09%181.5M | 21.89%188.8M | 21.71%196.2M |
-Total tax payable | ---- | ---- | ---- | ---- | ---- | 51.35%157.4M | 51.35%157.4M | ---- | ---- | ---- |
Current accrued expenses | ---- | ---- | ---- | ---- | ---- | 18.74%79.2M | 18.74%79.2M | ---- | ---- | ---- |
Current debt and capital lease obligation | -77.51%32.5M | -77.51%32.5M | -72.89%32.8M | -78.16%26.4M | -82.35%21.2M | 311.68%144.5M | 311.68%144.5M | 611.76%121M | 763.57%120.9M | 991.82%120.1M |
-Current debt | -73.18%32.5M | -73.18%32.5M | -72.89%32.8M | -78.16%26.4M | -82.35%21.2M | 548.13%121.2M | 548.13%121.2M | 611.76%121M | 763.57%120.9M | 991.82%120.1M |
-Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | 42.07%23.3M | 42.07%23.3M | ---- | ---- | ---- |
Current deferred liabilities | 10.40%441.6M | 10.40%441.6M | 22.43%466.7M | 26.30%501.9M | 21.97%485.2M | 8.05%400M | 8.05%400M | 117.21%381.2M | 102.03%397.4M | 85.28%397.8M |
Other current liabilities | 1,012.74%576.4M | 1,012.74%576.4M | 53.14%595.1M | 61.69%555.9M | 42.64%477M | 117.65%51.8M | 117.65%51.8M | -24.46%388.6M | -24.07%343.8M | -32.25%334.4M |
Current liabilities | 6.86%1.28B | 6.86%1.28B | 23.30%1.32B | 24.13%1.3B | 12.78%1.18B | 31.48%1.2B | 31.48%1.2B | 24.02%1.07B | 28.41%1.05B | 19.08%1.05B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 66.93%2.06B | 66.93%2.06B | 117.09%2.39B | 99.85%2.24B | 30.12%1.44B | -0.02%1.24B | -0.02%1.24B | -3.36%1.1B | -4.14%1.12B | -8.00%1.11B |
-Long term debt | 77.70%2.06B | 77.70%2.06B | 106.13%2.26B | 89.93%2.13B | 22.39%1.36B | -3.35%1.16B | -3.35%1.16B | -3.36%1.1B | -4.14%1.12B | -8.00%1.11B |
-Long term capital lease obligation | ---- | ---- | --120.5M | --111.3M | --85.7M | 114.94%74.8M | 114.94%74.8M | ---- | ---- | ---- |
Non current deferred liabilities | ---- | ---- | --272.6M | --272.4M | --187.4M | -2.87%159.2M | -2.87%159.2M | ---- | ---- | ---- |
Employee benefits | ---- | ---- | --83.8M | --79.6M | --76M | 67.61%76.6M | 67.61%76.6M | ---- | ---- | ---- |
Preferred securities outside stock equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.9M | --12M |
Other non current liabilities | 296.58%648.8M | 296.58%648.8M | -49.00%206.3M | -57.65%178.3M | -57.86%166.7M | 35.43%163.6M | 35.43%163.6M | 5.95%404.5M | 4.03%421M | -7.29%395.6M |
Total non current liabilities | 65.84%2.71B | 65.84%2.71B | 96.11%2.95B | 78.32%2.77B | 23.51%1.87B | 4.39%1.63B | 4.39%1.63B | -1.02%1.5B | -1.29%1.56B | -7.08%1.52B |
Total liabilities | 40.84%4B | 40.84%4B | 65.79%4.27B | 56.47%4.08B | 19.12%3.06B | 14.38%2.84B | 14.38%2.84B | 8.06%2.58B | 8.86%2.61B | 2.09%2.57B |
Shareholders'equity | ||||||||||
Share capital | ---- | ---- | 5.88%1.8M | 5.88%1.8M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M |
-common stock | ---- | ---- | 5.88%1.8M | 5.88%1.8M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M | 0.00%1.7M |
-Preferred stock | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | ---- | ---- | --2.4B | --2.37B | --2.37B | 20.65%2.32B | 20.65%2.32B | ---- | ---- | ---- |
Paid-in capital | ---- | ---- | --704.1M | --701.3M | --291.1M | 10.38%282.9M | 10.38%282.9M | ---- | ---- | ---- |
Less: Treasury stock | ---- | ---- | 4.24%1.24B | 11.74%1.24B | 11.74%1.24B | 14.03%1.24B | 14.03%1.24B | 12.12%1.19B | 12.27%1.11B | 19.58%1.11B |
Gains losses not affecting retained earnings | ---- | ---- | -1,098.08%-62.3M | -280.33%-44M | -126.01%-7.7M | -59.46%6M | -59.46%6M | 94.35%-5.2M | 149.49%24.4M | 273.10%29.6M |
Other equity interest | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 15.01%2.4B | 15.37%2.31B | 15.21%2.26B |
Total stockholders'equity | 30.49%1.8B | 30.49%1.8B | 49.49%1.81B | 45.32%1.79B | 19.91%1.42B | 23.65%1.38B | 23.65%1.38B | 29.01%1.21B | 26.86%1.23B | 16.06%1.18B |
Noncontrolling interests | -49.86%18.1M | -49.86%18.1M | 1.98%36.1M | 81.03%35.3M | 91.89%35.5M | 100.56%36.1M | 100.56%36.1M | 111.98%35.4M | -3.47%19.5M | -12.32%18.5M |
Total equity | 28.44%1.82B | 28.44%1.82B | 48.14%1.84B | 45.88%1.82B | 21.02%1.45B | 24.87%1.41B | 24.87%1.41B | 30.46%1.24B | 26.24%1.25B | 15.48%1.2B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |